AINDEX
Markets

Beta Bionics, Inc. (BBNX)

BBNXNASDAQ-GMMedical/Dental Instruments

$16.42

-0.4100 (-2.44%) today

Closed, Nov 13, 4:00 PM ET

-2.44% 1D
Market cap
$892.71m
P/E
–
EPS, last 4 quarters
$-1.84
Dividend yield
–
Day range
–
52-week range
$8.80 to $32.71
Average volume
–
Previous close
$16.83

Analysts

13 covering

Buy9 buy, 4 hold, 0 sell

Targets a year out average $24.83, +51.2% from here

$16.00now $16.42$30.00

Earnings

next estimate $-0.5000

Next report

Dec 2025

+28.6%

Mar 2026

+7.5%

Jun 2026

+14.5%

Sep 2026

+1.9%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$32.12m$27.63m$32.01m$35.51m
Gross profit$18.94m$16.44m$18.90m$20.33m
Operating income-$16.12m-$24.27m-$25.58m-$26.61m
Net income-$13.47m-$21.89m-$23.40m-$24.35m

Last four quarters: revenue $127.27m, margin -65.3%, free cash flow -$65.96m

News

8 latest

The company

Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease.

Sector
Health Care
Industry
Medical/Dental Instruments
Exchange
NASDAQ-GM
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.